Back to Digest
Other  · Jun 01, 2026

Eradivir Round 5 a series of Allocations 2026 Master, LLC

SEC Filing Record
Offering Amount
$0.3M
Strategy
Other
Exemption
06b
Date Filed
Jun 01, 2026
0002131989-26-000001
View on SEC EDGAR →
37A Read

The $0M target indicates a placeholder filing; the three-GP structure—two LLCs plus named individual Richard Thoms—signals either a feeder vehicle collecting capital into a master fund or a continuation series where fund administration is separated from investment decision-making, a pattern common when managers scale beyond a single GP entity.

The absence of any prior EDGAR filings from this manager means this is either a first-time SEC registrant or a previously untracked operator; the 06b exemption (pre-existing relationships only) combined with a multi-entity GP structure suggests the manager is bootstrapping from a closed LP network rather than building institutional distribution infrastructure.

Filing in June 2026 during a period when LP dry powder remains elevated and exit markets have stabilized makes sense for a continuation or follow-on raise, though the placeholder offering size and lack of manager history raise questions about whether this filing is exploratory or holds genuine near-term capital deployment plans.

Before allocating, confirm whether Richard Thoms holds key-man rights, what percentage of capital each GP entity actually controls, and whether the two LLCs (Istanbul New Ventures and Allocations Fund Administration) have overlapping LP bases or represent distinct investor syndicates—this affects fee splits, governance, and potential conflicts.

Full analysis (GP structure, exemption breakdown, and market context) is available to Pro members.

Unlock Pro · $29/month → Sign in
Principals
General Partners & Executives
LLC Istanbul New Ventures LLC Allocations Fund Administration, Richard Thoms